These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 6292543

  • 1. [Susceptibility of recent clinical isolates of Pseudomonas aeruginosa and Serratia marcescens to cefotaxime, ceftizoxime, cefmenoxime, latamoxef and cefsulodin in comparison with other beta-lactam antibiotics and aminoglycosides].
    Kawakami Y, Okimura Y, Horiuchi N, Kanai M.
    Jpn J Antibiot; 1982 Sep; 35(9):2314-7. PubMed ID: 6292543
    [No Abstract] [Full Text] [Related]

  • 2. [Combination action of sisomicin, dibekacin and cefotetan, cefotaxime, latamoxef, and cefsulodin against Escherichia coli, Serratia marcescens, and Pseudomonas aeruginosa].
    Saito M, Azuma K, Nishino T, Tanino T.
    Jpn J Antibiot; 1983 Oct; 36(10):2833-43. PubMed ID: 6325746
    [Abstract] [Full Text] [Related]

  • 3. [Studies on the combination action of sisomicin, gentamicin and cefmenoxime, ceftizoxime, cefoperazone, cefotetan against Serratia marcescens and Pseudomonas aeruginosa].
    Kubo M, Kato Y, Inamori Y.
    Jpn J Antibiot; 1985 Dec; 38(12):3487-96. PubMed ID: 3938819
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity of cefotaxime, ceftizoxime, cefmenoxime, and latamoxef in comparison with other beta-lactam antibiotics against recent clinical isolates of Haemophilus influenzae and Haemophilus parainfluenzae.
    Kawakami Y, Okimura Y, Horiuchi N, Kanai M.
    Microbiol Immunol; 1982 Dec; 26(7):617-21. PubMed ID: 6290854
    [No Abstract] [Full Text] [Related]

  • 5. [Antibacterial activities of new cephems against clinically isolated organisms (author's transl)].
    Okada K, Kawamura N, Ohkoshi M, Satake Y, Kawakita J.
    Jpn J Antibiot; 1982 Apr; 35(4):1009-21. PubMed ID: 6285019
    [Abstract] [Full Text] [Related]

  • 6. In vitro activity of newer beta-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens.
    Meyer RD, Pasiecznik K.
    Diagn Microbiol Infect Dis; 1983 Dec; 1(4):287-93. PubMed ID: 6321092
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the beta-lactamase stability and the in-vitro activity of cefoperazone, cefotaxime, cefsulodin, ceftazidime, moxalactam and ceftriaxone against Pseudomonas aeruginosa.
    Livermore DM, Williams RJ, Williams JD.
    J Antimicrob Chemother; 1981 Oct; 8(4):323-31. PubMed ID: 6271726
    [No Abstract] [Full Text] [Related]

  • 8. The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibiotics.
    Neu HC.
    Annu Rev Pharmacol Toxicol; 1982 Oct; 22():599-642. PubMed ID: 6282190
    [No Abstract] [Full Text] [Related]

  • 9. [Antibacterial activity of cefmenoxime against clinical isolates. Comparative study].
    Takahashi C, Miyazawa K.
    Jpn J Antibiot; 1985 Jan; 38(1):27-30. PubMed ID: 3886949
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Agar (disk) diffusion test susceptibility of clinical isolates of Pseudomonas aeruginosa to azlocillin, cefotaxime, cefsulodin, lamoxactam, mezlocillin, and piperacillin.
    Traub WH.
    Chemotherapy; 1982 Jan; 28(4):257-60. PubMed ID: 6288329
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vitro activity and beta-lactamase stability of cefmenoxime.
    Neu HC, Labthavikul P.
    Antimicrob Agents Chemother; 1982 Aug; 22(2):316-22. PubMed ID: 6100427
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli.
    Kurtz TO, Winston DJ, Hindler JA, Young LS, Hewitt WL, Martin WJ.
    Antimicrob Agents Chemother; 1980 Oct; 18(4):645-8. PubMed ID: 6255864
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vitro combination effects of cefsulodin, moxalactam and cefoperazone with four aminoglycosides on nonfermenting nosocomial gram-negative bacteria.
    Daschner FD, Steffens A, Mählmann M, Metzger M.
    Arzneimittelforschung; 1982 Oct; 32(5):531-3. PubMed ID: 6213241
    [Abstract] [Full Text] [Related]

  • 20. Comparative in vitro activity of aztreonam, other beta-lactam antibiotics and aminoglycosides against Pseudomonas aeruginosa.
    Venditti M, Brandimarte C, Santini C, Valente B, Martino P, Serra P.
    Chemioterapia; 1984 Aug; 3(4):258-61. PubMed ID: 6442625
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.